PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.520
+0.170 (3.91%)
At close: Feb 6, 2026, 4:00 PM EST
4.520
0.00 (0.00%)
After-hours: Feb 6, 2026, 4:00 PM EST
PolyPid Market Cap
PolyPid has a market cap or net worth of $75.19 million as of February 6, 2026. Its market cap has increased by 241.10% in one year.
Market Cap
75.19M
Enterprise Value
57.91M
1-Year Change
241.10%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $75.19M, a decrease of -8.79%. That is a compound annual growth rate of -1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 72.36M | 0.23% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 77.17M |
| iBio, Inc. | 77.12M |
| MAIA Biotechnology | 76.34M |
| ImageneBio | 74.50M |
| XBiotech | 72.87M |
| MindWalk Holdings | 72.84M |
| Immunic | 72.62M |
| Pelthos Therapeutics | 71.69M |